#89: NewsBot: Alnylam Initiates Phase II Trial to Evaluate Safety and Tolerability of ALN-RSV01 in Adult Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus (RSV) Infection
Alnylam Initiates Phase II Trial to
Evaluate Safety and Tolerability of ALN-RSV01... |
April 13, 2008
03:49:39 PM |
#88: FastFun: Alnylam to Webcast Presentation at the 19th Annual Piper Jaffray Health Care Conference with Focus on Intellectual Property
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company,... |
November 26, 2007
07:16:23 AM |
#87: FastFun: Regulus Therapeutics Announces Allowance of Key Patent on microRNA Therapeutics for the Treatment of Hepatitis C Virus Infection
New Patent Strengthens Regulus’ Leadership in microRNA Therapeutics
... |
November 26, 2007
07:13:54 AM |
#86: NewsBot: ALNY News Alnylam Grants Bio-Rad License to Kreutzer-Limmer Patents for the RNA Interference (RNAi) Research Products Market
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a... |
March 29, 2007
05:00:00 AM |
#85: NewsBot: ALNY News Alnylam to Webcast Presentation at 2007 Future Leaders in the Biotech Industry Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a... |
March 23, 2007
05:00:00 AM |
#84: NewsBot: ALNY News Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a... |
March 22, 2007
12:16:00 PM |
#83: NewsBot: ALNY News Alnylam to Webcast Presentation at the Lehman Brothers Tenth Annual Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a... |
March 13, 2007
01:00:00 PM |
#82: NewsBot: ALNY News Alnylam to Webcast at the Cowen and Company 27th Annual Health Care Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a... |
March 7, 2007
02:01:00 PM |
#81: NewsBot: ALNY News Alnylam and Isis Announce Allowance of First U.S. Patent Covering Human microRNAs
CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Alnylam Pharmaceuticals,... |
March 1, 2007
04:00:00 AM |
#80: NewsBot: ALNY News Alnylam Scientist Awarded Two Industry Honors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a... |
February 28, 2007
05:00:00 AM |
#79: NewsBot: ALNY News Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
CAMBRIDGE, Mass. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Alnylam... |
January 9, 2007
05:00:00 AM |
#78: NewsBot: ALNY News Alnylam Announces Key Product and Business Goals for 2007
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a... |
January 8, 2007
05:01:00 AM |
#77: NewsBot: ALNY News Alnylam to Webcast Presentation at the 25th Annual JPMorgan Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a... |
January 3, 2007
04:30:00 AM |
#76: NewsBot: ALNY News Alnylam Announces Closing of Common Stock Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY)... |
December 15, 2006
01:01:00 PM |
#75: NewsBot: ALNY News Alnylam Announces Proceeds of Common Stock Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY)... |
December 12, 2006
01:01:00 PM |
| 
| 
| 
| 
| 
| 
